wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q55015991-8B82DFE5-7E58-4B39-9AC6-725B47524FCA
Q55015991-8B82DFE5-7E58-4B39-9AC6-725B47524FCA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55015991-8B82DFE5-7E58-4B39-9AC6-725B47524FCA
Targeted Therapies for Pancreatic Cancer.
P2860
Q55015991-8B82DFE5-7E58-4B39-9AC6-725B47524FCA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55015991-8B82DFE5-7E58-4B39-9AC6-725B47524FCA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c27e90285a4e6c597f58ca74d820de65fdf30ddd
P2860
Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study.